4.2 Review

Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments

期刊

CURRENT OSTEOPOROSIS REPORTS
卷 17, 期 1, 页码 1-7

出版社

SPRINGER
DOI: 10.1007/s11914-019-00498-x

关键词

Glucocorticoids; Bone cells; Bone vascularity; Osteonecrosis; Parathyroid hormone

资金

  1. NIAMS NIH HHS [P50 AR060752, P50 AR063043, K24 AR048841] Funding Source: Medline

向作者/读者索取更多资源

Purpose of this ReviewThe goal of the review is to provide an updated understanding of the pathophysiology of glucocorticoid-induced osteoporosis and treatment recommendations.Recent FindingsGlucocorticoids reduce osteoblast and osteocyte lifespan and activity and reduce the vascularity of the bone that together may explain the greater reductions in bone strength than those of bone mass. Treatments with parathyroid hormone fragments appear to reverse glucocorticoid-induced bone loss and fracture risk partially through maintaining bone vascularity and bone strength.SummaryThis review identifies how glucocorticoid anti-osteogenic and vascular effects together may reduce bone strength. It also provides guidance to clinicians on rationale treatment for glucocorticoid-induced osteoporosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据